$2.77
-0.03 (-1.07%)
Enzo Biochem, Inc. (NYSE:ENZ)
CAPS Rating:
The Company is a life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and a provider of diagnostic services to the medical community.
RSS Headlines
Fool UK